Table 9.
Cancers | Targeted gene products† | References |
---|---|---|
Cancers with down-regulation of miR-203a-3p | ||
Acting as oncogenes or tumor promoters | ||
CRC | TYMS | Li et al. (2015a) |
Glioblastoma | TYMS | Chen et al. (2017b) |
NSCLC | AVL9, BIRC5, DLX5, E2F1, ZEB2 | Liang et al. (2020); Yang et al. (2020); Wang et al. (2020a) |
BLCA | SIX4 | Na et al. (2019) |
PDAC | SNAI2 | An and Zheng (2020 |
Acting both as oncogenes and tumor suppressors, or unclassified | ||
CRC | THBS2 | Qian et al. (2019) |
GC | IGF1R | Wang et al. (2018a) |
OVCA | ATM | Liu et al. (2019a) |
Cancers with up-regulation of miR-203a-3p | ||
Acting as tumor suppressors | ||
HCC | IL24, PTEN | Huo et al. (2017); Zhang et al. (2020) |
Acting both as oncogenes and tumor suppressors, or unclassified | ||
CRC | PDE4D | Chen et al. (2018) |
†mRNAs encoding the following proteins: ATM codes for ATM Serine/Threonine Kinase (Ataxia Telangiectasia Mutated), although it is considered as a tumor suppressor, ATM signaling can be involved in chemoresistance of cancer cells (Cremona and Behrens 2014) as well as promote the EMT process (Liu et al. 2019a); AVL9 codes for cell migration associated protein and is an oncogene in NSCLC; BIRC5 can be regarded as an oncogene that codes for apoptosis inhibitor Survivin; DLX5 codes for transcriptional activator and acts as oncogene (Tan and Testa 2021); E2F1 encodes E2F Transcription Factor 1; IGF1R encodes the Insulin-like Growth Factor 1 Receptor (Werner et al. 2016); IL24 codes for interleukin 24, which can induce apoptosis in a variety of cancer cells, thereby acting as a tumor suppressor; PDE4D encodes cAMP-specific Phosphodiesterase 4D; PTEN is a tumor suppressor gene encoding Phosphatase and Tensin Homolog; SIX4 codes for transcriptional regulator and acts as oncogene; THBS2 codes for Thrombospondin 2; SNAI2 codes for SLUG which represses the gene encoding E-cadherin and thus promotes the EMT process of cancer cells